In the 2024 election, seven out of 10 states passed ballot measures protecting abortion rights. But the effects won't be seen ...

As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives ...

NationsBenefits, a fintech, benefits and outcomes platform, has acquired food-as-medicine company Good Measures, the companies announced Tuesday. Plantation, Florida-based NationsBenefits is a ...

Prior authorization has been a bone of contention between payers and providers for some time now. Payers argue that it helps avoid unnecessary care and reduces costs, while providers say it ...

Mobility and transportation challenges make accessing healthcare a daunting endeavor for many individuals who need care. Whether it’s navigating the physical barriers of a doctor’s office ...

Fort Health, an integrated behavioral health company, has secured $5.5 million, it announced Tuesday. It will use these funds to bring mental health services into more pediatricians’ offices in ...

According to the U.S. Census Bureau, the entire baby boom generation will be age 65 or older by 2030. Many boomers will move into senior living environments. The National Investment Center for ...

Like many insurers, UnitedHealthcare and Optum are dealing with a surge in digital solutions, according to Dr. Debra Nussbaum, senior director of behavioral health at Optum. And they’re trying ...

Otsuka Pharmaceutical’s North American CEO —Tarek Rabah — has deep respect for all the entrepreneurs who were at at the annual HLTH conference in Las Vegas touting their capabilities.

From L-R: Betty Pio, partner at Kearney; Dr. Rekha Kumar, chief medical officer at Found and practicing endocrinologist at New York-Presbyterian; Sheila Shah, managing director, L.E.K. Consulting ...

Trust between patients and providers is the backbone of the healthcare industry, making it necessary for the healthcare workforce to reflect the breadth of backgrounds, races and creeds of the ...

An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among other developmental delays now has its first FDA-approved treatment. The new product, a gene therapy ...